Financial News

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Piper Sandler 34th Annual Healthcare Conference
Presentation: Tuesday, November 29, 2022 at 9:30 am ET
Location: Lotte New York Palace Hotel, New York, NY

5th Annual Evercore ISI HealthCONx Virtual Conference
Fireside chat: Thursday, December 1 at 3:05 pm ET

The JMP Securities Hematology and Oncology Virtual Summit
Fireside chat: Tuesday, December 6, 2022 at 1:20 pm ET

A live webcast and archived replay of the presentation and fireside chats will be available on the investors section of our website, linked here:

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit:


Media & Investors
Sarah Spencer
+1 857-242-6076


Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info